Europe Chronic Kidney Disease Epidemiology and Patient Flow Analysis - 2017

Europe Chronic Kidney Disease Epidemiology and Patient Flow Analysis - 2017

  • January 2017 •
  • Report ID: 4835110 •
  • Format: PDF
Fore Pharma announced the results of its Chronic Kidney Disease patients study in a new report ‘Europe Chronic Kidney Disease Epidemiology and Patient Flow Analysis - 2017’.

The report provides insights into Chronic Kidney Disease epidemiology, Chronic Kidney Disease diagnosed patients, and Chronic Kidney Disease treatment rate for EU5 pharmaceutical markets. The study measures key indicators such as prevalence of Chronic Kidney Disease derived from epidemiological analysis, percentage of patients diagnosed with Chronic Kidney Disease, and percentage of patients treated with a therapy.

The study helps executives estimate Chronic Kidney Disease market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Chronic Kidney Disease prevalence, Chronic Kidney Disease diagnosis rate, and Chronic Kidney Disease treatment rate for the period 2016 - 2025. The information is presented by leading geographies including Germany, France, Spain, Italy, and UK. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:
- Chronic Kidney Disease Patient Flow
- Chronic Kidney Disease Prevalence
- Chronic Kidney Disease Diagnosed Patients
- Chronic Kidney Disease Treated Patients